Protagenic Therapeutics, Inc.new insider trading activity

Understanding Insider Activity at Protagenic Therapeutics, Inc.new

Welcome to our dedicated page for Protagenic Therapeutics, Inc.new (Nasdaq: PTIX) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Protagenic Therapeutics, Inc.new's key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Protagenic Therapeutics, Inc.new, and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for PTIX
TickerTime & DateFilingLink
PTIX4:48:45 PM, 10/13/2023
Arrow Alexander K.(Chief Financial Officer) purchased 8000 shares of Protagenic Therapeutics, Inc.\new (PTIX) for ~$6480
Filing